Quick Takeaways
- This page summarizes Daniel M. Junius's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 2 reported transactions and 2 derivative rows are listed below.
- Filing timestamp: 13 May 2022, 17:42.
Daniel M. Junius - 11 May 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Role
- Director
- Signature
- /s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius
- Issuer symbol
- IDXX
- Transactions as of
- 11 May 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 13 May 2022, 17:42:19 UTC
- Previous filing
- 03 May 2022
- Next filing
- 20 May 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Daniel M. Junius filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 13 May 2022."
What Changed
- Previous filing in this sequence was filed on 03 May 2022.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IDXX | Deferred Stock Unit | Award | +344 | 344 | 11 May 2022 | Common Stock | 344 | Direct | F1, F3 | ||||
| transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Award | +945 | 945 | 11 May 2022 | Common Stock | 945 | $333.90 | Direct | F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors. |
| F2 | Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier. |
| F3 | Not applicable. |